• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cubist Pharmaceuticals Inc

+ Add to Watchlist

CBST:US

66.7500 USD 0.5900 0.89%

As of 13:50:40 ET on 09/16/2014.

Snapshot for Cubist Pharmaceuticals Inc (CBST)

Open: 66.0200 Day's Range: 65.7300 - 66.9000 Volume: 339,235
Previous Close: 66.1600 52wk Range: 58.5000 - 82.1200 1-Yr Rtn: +3.65%

Stock Chart for CBST

No chart data available.
  • CBST:US 66.7000
  • 1D
  • 1M
  • 1Y
66.1600
Interactive CBST Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBST

Current P/E Ratio (ttm) 80.3584
Estimated P/E(12/2014) 59.5113
Relative P/E vs. SPX 4.5452
Earnings Per Share (USD) (ttm) 0.8187
Est. EPS (USD) (12/2014) 1.1050
Est. PEG Ratio 2.9756
Market Cap (M USD) 4,982.50
Shares Outstanding (M) 75.73
30 Day Average Volume 580,548
Price/Book (mrq) 3.3907
Price/Sale (ttm) 4.3487
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBST

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CBST

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment.

Michael Weston Bonney "Mike"Chief Executive OfficerRobert J Perez "Rob"President/COO
Thomas J Desrosier "Tom"Exec VP/Chief Legal Ofcr/SecySteven C Gilman "Steve"Exec VP:Research & Development
More Company Profile & Key Executives for CBST

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil